Sen. Bernie Sanders releases new report detailing the rigged system that allows Big Pharma to charge Americans the highest prices in the world for prescription drugs

The report also syst Americans y analyzes the launch prices of innovative prescription d The HELP Committee Majority Staff erck, and Brist three e U.S. quibb since 2004.

From 200 Johnson & Johnson di Merck unch p Bristol Myers Squibb rescription drugs sold by Johnso American son, Merck, and Bristol Myers Squibb was $14,000.

The billions of dollars lt patent thi Americans extend their monopolies and delay low-cost generic competition.

Medicare, for th U.S irst time, can negotiate the price of drugs like Eliquis and Stelara. Americans Johnson & Johnson di Merck /span> Bristol Myers Squibb ryFeed_ 2004 LightText__NxlGi">Stelara U.S. iquis < twenty years ago ar Key Findings Include _NxlGi">first Medicare< Johnson & Johnson ss Merck maryFe Bristol Myers Squibb lGi">Congre tens of billions of dollars maryFeed_highLight 2022 __ Johnson & Johnson $17.9 billion s="summaryFeed_highLightText__Nxl $27.6 million That year ryFeed_highLightText $17.8 billion million more tha just $14.6 billion an> Bristol Myers Squi $3.2 billion span class="summaryFeed_highLightText__NxlGi">Merck 2022 ar Bristol Myers Squibb _NxlGi $6.3 billion Johnson $41.4 million tText__NxlGi">the That year ty years $12.7 billion maryFeed_highLightText__NxlGi">FDA just $9.5 billion ">79% Johnson & Johnson ed Bristol Myers Squibb i">Stel $3.2 billion Johnson & Johnson’s 2022 pa Merck ss="su $14.5 billion hLightText__NxlGi">57 $52.5 million "summaryFeed_highL That year _NxlGi">first over $7 billion summaryFeed_highLightText__NxlGi">64% $13.6 billion summaryFeed_ Merck ightText__NxlGi Keytruda da 2022 yFeed_highLightText McDonald’s e annual pan> Marriott an> the Drug Patent American an> Johnson & Johnson s Merck bBristol Myers Squibb maryFeed_highLightText__ U.S. i">Merck 2016 tT Johnson & Johnson on Stelara 38,000U.S. > $30.4 billion "summaryFeed_highLightText__NxlGi">thr $14.9 billion pan class=" 2015 ar Merck _highL $43.4 billion Gi">the past five yearsKeytruda span cla U.S. summaryFeed_h $30 billion t__NxlGi">14,000 Bristol Myers Squibb _highL $34.6 billion Gi">Bristol Myers Squibb U.S. summaryFeed_h $22.5 billion _NxlGi">Merck U.S. ighLightText__ nearly two-thirds Johnson Johnson ri Merck /span> Bristol Myers Squibb ryFeed_h Americans ext__NxlGi">U.S. Bristol Myers Squibb Merck Johnson Merck _NxlGi">U.S. Keytruda "sum 2015 Feed_hi annual tText__Nxl 147,000 00U.S. span c 132,000 umma Germany highLigh Keytruda xlGi">Brist just $89,000 ibb< Germany U.S. ">U.S 191,000 > < Bristol Myers Squibb eed_highLightTe Eliquis Gi"> 2013 /span> annual class="sum 3,100 eed_high U.S. tText just $1,000 pan< Japan > Eliquis